US Asthma Treatment Market Value to Hit $14 Billion by 2020, says GBI Research
18 March 2015 | By Victoria White
GBI Research reports that the US asthma treatment market value will increase from $11.7 billion in 2013 to an estimated $14 billion...
List view / Grid view
18 March 2015 | By Victoria White
GBI Research reports that the US asthma treatment market value will increase from $11.7 billion in 2013 to an estimated $14 billion...
18 March 2015 | By Victoria White
Novartis announce that the EU has approved Jakavi ® for the treatment of adult patients with polycythemia vera (PV)...
18 March 2015 | By Victoria White
The US pharmaceutical market is forecast to increase to $548.4 billion by 2020 according to research and consulting firm GlobalData...
18 March 2015 | By Shimadzu
Shimadzu Scientific Instruments has introduced two new integrated liquid chromatography systems, Prominence-i and Nexera-i, adding to the company’s extensive line-up of HPLC and UHPLC systems...
17 March 2015 | By Victoria White
AF patients considered at high risk for stroke may not be receiving recommended treatment as revealed in analyses from the GLORIA™-AF Registry Program...
17 March 2015 | By Victoria White
ESCMID has joined the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ on April 24th, 2015...
17 March 2015 | By Waters
New RapiFluor-MS Labeling Reagent & Sample Preparation Protocol Enhances Speed, Sensitivity, Simplicity of Released N-Glycan Profiling & Characterization...
16 March 2015 | By The International Society of Nephrology
The International Society of Nephrology (ISN) will present the findings of a new global study on Acute Kidney Injury (AKI), seen by experts as a key step forward in their efforts to eliminate preventable deaths from the condition by 2025 (0by25)...
16 March 2015 | By BioTrinity / Peel Hunt
New research from BioTrinity and Peel Hunt shows $2.9bn raised in 2014...
CAMO Software will be arranging their 2015 User Meeting in Prague, Czech Republic on 16th – 17th April...
13 March 2015 | By Actavis
Actavis plc announced that the U.S. Food and Drug Administration has approved its supplemental new drug application (sNDA) for SAPHRIS® (asenapine) as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients...
13 March 2015 | By Novartis
Novartis announced that new results for Cosentyx(TM) (secukinumab) in moderate-to-severe plaque psoriasis, including detailed findings from the head-to-head CLEAR study and long-term data from the Phase III program, will be presented as late breaking research at the 73rd Annual Meeting of American Academy of Dermatology...
12 March 2015 | By The National Children’s Bureau
Anna Feuchtwang, Chief Executive of the National Children’s Bureau, said: “The National Children’s Bureau, welcomes the Children and Young People’s Health Outcomes Forum’s (CYPHOF) annual report, which shows that despite improvements, progress on child health outcomes has not been fast enough in children and young people’s health care services..."
12 March 2015 | By NHS Confederation
Responding to NHS England’s announcement on transforming patient care, Rob Webster, chief executive of the NHS Confederation, said: “Today’s naming of 29 vanguard sites, many of which are our members, is to be welcomed..."
12 March 2015 | By Public Health England Press Office
"We can confirm that a UK military healthcare worker in Sierra Leone has tested positive for Ebola. Medical experts are currently assessing the situation to ensure that appropriate care is delivered..."